3M Health Information Systems as entered an agreement with Verily (formerly Google Life Sciences) to develop new population health measurement technology. The joint platform will work to assess quality performance data across healthcare delivery systems and patient populations, providing actionable insights that can be used to make improvements in healthcare quality and cost. The platform will...
Watching a weather app to see if a cold front is coming in has taken on a new meaning: The Cold and Flu Tracker app, where people can get updates on cold and flu activity at a hyperlocal level, is now available to users thanks to a partnership with GlaxoSmithKline Consumer Healthcare’s Theraflu and the Weather Company.
Beyond mixing sickness with weather, the app is also part of GSK’s overall...
When Apple announced ResearchKit in March 2015, and unveiled the first five apps to test-drive the company’s new approach to clinical research, the announcement made a big splash. And indeed, in the weeks following, those apps posted incredible recruitment figures: for instance, Parkinson’s emPower study saw 5,500 sign-ups by day two and ended up with more than 18,000 participants.
But there...
GlaxoSmithKline has launched the ResearchKit app that it told Buzzfeed it was working on more than a year ago, making it the first pharma company to get a ResearchKit study off the ground. The study is called PARADE, which the company says stands for Patient Rheumatoid Arthritis Data in the Real World.
"We are the first in our industry to use Apple’s ResearchKit as part of our research, this time...
Propeller Health and Boehringer Ingelheim announced a new commercial partnership. Under the partnership, COPD and asthma patients using Boehringer's Respimat inhaler will have the opportunity to enroll in a program at select health systems that will monitor their adherence via a Propeller sensor and improve their engagement in their health.
"So far we have developed a popular Bluetooth-enabled...
Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.
2Morrow’s smoking cessation app, called SmartQuit, is based on acceptance and commitment therapy, or an ACT-based program, that "focuses on increasing one’s willingness to accept the physical, mental...
Pharmaceutical giant GlaxoSmithKline (GSK) has offered up a new, free asthma management app, called MyAsthma, for iPhone and Android users in the UK. The app's core offering is an Asthma Control Test (ACT), which is a simple 30-second test that provides users with an index score for how well they are managing their asthma overall. UK-based Replay Digital developed the app for GSK. Dr. Mike Thomas...
